Filing Details
- Accession Number:
- 0001415889-21-004250
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-03 17:20:34
- Reporting Period:
- 2021-09-02
- Accepted Time:
- 2021-09-03 17:20:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1778070 | F Andrea Wainer | 100 Abbott Park Road Abbott Park IL 60064 | Executive Vice President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares Without Par Value | Acquisiton | 2021-09-02 | 4,500 | $47.00 | 54,282 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Acquisiton | 2021-09-02 | 5,000 | $38.40 | 59,282 | No | 4 | M | Direct | |
| Common Shares Without Par Value | Disposition | 2021-09-02 | 9,500 | $127.50 | 49,782 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Option (right to buy) | Disposition | 2021-09-02 | 4,500 | $0.00 | 4,500 | $47.00 |
| Common Shares | Option (right to buy) | Disposition | 2021-09-02 | 5,000 | $0.00 | 5,000 | $38.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 38,226 | 2016-02-20 | 2025-02-19 | No | 4 | M | Direct |
| 30,000 | 2017-02-19 | 2026-02-18 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
